Stocks Screener

Search any stock or ticker

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

How This Company Makes Money

Dividend Analysis CUV

Max Ratio

Dividend Yield

0.41 %

5Y Dividend Growth

100.00 %

Consecutive Years

5Y Average Payout Ratio

7.66 %

Dividend History CUV

1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021
Forward Annual Dividend Yield 0.41 %
Consecutive Years 0
Forward Annual Dividend 0.050 AUD
Consistent Years 6
Dividend CAGR 3Y 25.99 %
Continuous Dividends
Dividend CAGR 5Y 14.87 %
Payout Ratio TTM 6.96 %
Dividend CAGR 10Y
Ex Dividend Date 09/04/2025

The 5 Pillars Formula Checklist

The Five-Pillar Secret Formula Checklist is our simple, proven way to separate strong, lasting businesses from the rest. We look at five key pillars—sales growth, profit growth, Net Income, dividend safety, and debt levels. Together with Financial Score, they tell us if a company can keep growing, stay financially solid, and reliably pay dividends for decades.

Sales Growth CUV

Sales Growth – The Foundation of a Strong Business. Consistent revenue growth over the past 10-15 years is a key sign of a thriving company. It shows that demand for its products and services is increasing, allowing it to expand operations, gain market share, and invest in future growth.
1 year
3 years
5 years
10 years

Profit Growth / Profit Margin CUV

The Fuel for Company Growth. Revenue alone isn’t enough—what truly matters is how efficiently a company turns that revenue into consistent, growing profits. Profitability is the foundation of sustainable growth and long-term financial strength.
1 year
3 years
5 years
10 years

Net Income CUV

The True Measure of Financial Strength. Net income is what remains after all expenses, taxes, and costs. This is the company’s real earning power.
1 year
3 years
5 years
10 years

Payout Ratio TTM CUV

Dividend Payout Safety – Protecting Your Passive Income. A high dividend yield is meaningless if the company can’t afford to sustain it. We evaluate payout ratios to ensure the company is not overextending itself. The best companies have a balanced approach—paying generous dividends while still reinvesting in future growth. Dividend safety is crucial for long-term income stability.
1 year
3 years
5 years
10 years
15 years
11/21/2021 - 11/28/2021

Debt Ratio CUV

Debt Burden – Avoiding Financial Traps. Too much debt can cripple a company, even if its revenues and profits look great. We analyze how well a company manages its liabilities, ensuring that debt levels are under control.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021

Full Financial Performance

See how the company makes money over time—revenue, profits, dividends, and more. The charts on the right give you a quick view of growth trends so you can instantly spot consistency or red flags.

Clinuvel Pharmaceuticals Ltd CUV

1 year
3 years
5 years
10 years
Results 2019 Dynamics
* The data for this period has not yet been published

Bottom Line

Valuation Check

Shows if a stock is priced fairly by looking at peers and the company’s own history — a quick way to see if it’s a bargain or overpriced.

Value vs Peers

The company is measured against at least 10 rivals in the same sector. If it earns 25% more profit per share than the average, it’s Undervalued. If it earns 25% less, it’s Overvalued. In short: stronger earnings per share mean you’re getting a bargain, weaker ones mean you’re overpaying.

Value vs Itself CUV

P/E shows how many dollars investors pay in the stock price for each $1 of profit the company earns per share. Today’s P/E is compared with the company’s 10-year average. If the ratio is above that norm, you’re paying up for each dollar of profit. If it’s below, you’re getting more earnings for less.
1 year
3 years
5 years
10 years
11/21/2021 - 11/28/2021
Trailing PE 16.92
Forward PE 15.92
Enterprise Value Revenue 3.92
Price Sales TTM 6.44
Enterprise Value EBITDA 6.52
Price Book MRQ 2.48

Clinuvel Pharmaceuticals Ltd Dividends: 0.41 % Yield, History, Payment Schedule

CUV
Current price
12.33 AUD +0.17 AUD (+1.40%)
Last closed 12.16 AUD
ISIN AU000000CUV3
Sector Healthcare
Industry Biotechnology
Exchange Australian Securities Exchange
Capitalization 607 345 315 AUD
Yield for 12 month -2.76 %
1Y
3Y
5Y
10Y
15Y
CUV
11/21/2021 - 11/28/2021

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Advanced Highlights

Current Year

+94 380 478 AUD

Last Year

+87 587 072 AUD

Current Quarter

+58 973 600 AUD

Last Quarter

+35 409 143 AUD

Current Year

+78 606 707 AUD

Last Year

+79 905 813 AUD

Current Quarter

+40 331 752 AUD

Last Quarter

+32 370 472 AUD
EBITDA 46 231 978 AUD
Operating Margin TTM 49.67 %
Price to Earnings 16.92
Return On Assets TTM 11.37 %
PEG Ratio
Return On Equity TTM 16.30 %
Wall Street Target Price 35.94 AUD
Revenue TTM 94 380 475 AUD
Book Value 4.77 AUD
Revenue Per Share TTM
Dividend Share 0.050 AUD
Quarterly Revenue Growth YOY 7.20 %
Dividend Yield 0.41 %
Gross Profit TTM 85 960 663 AUD
Earnings per share 0.72 AUD
Diluted Eps TTM 0.72 AUD
Most Recent Quarter II 2025
Quarterly Earnings Growth YOY -10.50 %
Profit Margin 38.07 %

Technical Indicators CUV

For 52 Weeks

9.30 AUD 13.84 AUD
50 Day MA 11.45 AUD
Shares Short Prior Month
200 Day MA 11.20 AUD
Short Ratio
Shares Short
Short Percent